SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-068586
Filing Date
2022-03-08
Accepted
2022-03-08 06:04:37
Documents
3
Group Members
CHENG-HSIEN LINCHIN-NU LINCHIN-PEN LINGEORGE YEHKEELUNG HONGSEA CREST HOLDING CORP.TAI-PING WUTEAL SEA HOLDING CORP.TIEN-HUO CHENTLC BIOSCIENCES CORP.YAN-HUEI LINYU-HUA LIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d309634dsc13da.htm SC 13D/A 211161
2 EX-99.1 d309634dex991.htm EX-99.1 9887
3 EX-99.2 d309634dex992.htm EX-99.2 97578
  Complete submission text file 0001193125-22-068586.txt   320300
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Subject) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90905 | Film No.: 22720229
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2F. NO. 3 YUANQU ST., NANGANG DIST. TAIPEI F5 105
Business Address
Lin Chang-Hai (Filed by) CIK: 0001813691 (see all company filings)

Type: SC 13D/A